Nanoviricides NNVC
NYSE NNVC
$1.41 +0.02 (+1.80%)
As of: Oct 23, 2026 · 3:58 PM EDT

Nanoviricides (NNVC) Gains from Sales and Divestitures (2020)

Updated

Nanoviricides (NNVC) posted Gains from Sales and Divestitures of -$2,026 for FY2021 (year ended Jun 30, 2021).

Analysis

Nanoviricides (NNVC) Gains from Sales and Divestitures (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Nanoviricides 28.26 Mn 15.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -2,026.00
API Access

Nanoviricides Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NNVC&period=max&api_key=YOUR_API_KEY